Immortalization capacity of HPV types is inversely related to chromosomal instability

High-risk human papillomavirus (hrHPV) types induce immortalization of primary human epithelial cells. Previously we demonstrated that immortalization of human foreskin keratinocytes (HFKs) is HPV type dependent, as reflected by the presence or absence of a crisis period before reaching immortality. This study determined how the immortalization capacity of ten hrHPV types relates to DNA damage induction and overall genomic instability in HFKs. Twenty five cell cultures obtained by transduction of ten hrHPV types (i.e. HPV16/18/31/33/35/45/51/59/66/70 E6E7) in two or three HFK donors each were studied. All hrHPV-transduced HFKs showed an increased number of double strand DNA breaks compared to controls, without exhibiting significant differences between types. However, immortal descendants of HPV-transduced HFKs that underwent a prior crisis period (HPV45/51/59/66/70-transduced HFKs) showed significantly more chromosomal aberrations compared to those without crisis (HPV16/18/31/33/35-transduced HFKs). Notably, the hTERT locus at 5p was exclusively gained in cells with a history of crisis and coincided with increased expression. Chromothripsis was detected in one cell line in which multiple rearrangements within chromosome 8 resulted in a gain of MYC. Together we demonstrated that upon HPV-induced immortalization, the number of chromosomal aberrations is inversely related to the viral immortalization capacity. We propose that hrHPV types with reduced immortalization capacity in vitro, reflected by a crisis period, require more genetic host cell aberrations to facilitate immortalization than types that can immortalize without crisis. This may in part explain the observed differences in HPV-type prevalence in cervical cancers and emphasizes that changes in the host cell genome contribute to HPV-induced carcinogenesis.

[1]  W. Quint,et al.  Longitudinal assessment of DNA methylation changes during HPVE6E7-induced immortalization of primary keratinocytes , 2015, Epigenetics.

[2]  Pieter Wesseling,et al.  DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly , 2014, Genome research.

[3]  C. Meijer,et al.  Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions , 2014, Nature Reviews Cancer.

[4]  C. Meijer,et al.  Differential In Vitro Immortalization Capacity of Eleven, Probable High-Risk Human Papillomavirus Types , 2013, Journal of Virology.

[5]  M. Holden,et al.  Identification of eight candidate target genes of the recurrent 3p12–p14 loss in cervical cancer by integrative genomic profiling , 2013, The Journal of pathology.

[6]  V. Beneš,et al.  Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. , 2013, Cancer cell.

[7]  Koenraad Van Doorslaer,et al.  Association between hTERT activation by HPV E6 proteins and oncogenic risk. , 2012, Virology.

[8]  V. Beneš,et al.  DELLY: structural variant discovery by integrated paired-end and split-read analysis , 2012, Bioinform..

[9]  C. Meijer,et al.  Chromosomal profiles of high‐grade cervical intraepithelial neoplasia relate to duration of preceding high‐risk human papillomavirus infection , 2012, International journal of cancer.

[10]  N. Barbosa-Morais,et al.  Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles , 2011, The Journal of pathology.

[11]  B. Kerem,et al.  Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development , 2011, Cell.

[12]  N. Carter,et al.  Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.

[13]  M. Donaldson,et al.  Human papillomavirus E1 and E2 mediated DNA replication is not arrested by DNA damage signalling. , 2010, Virology.

[14]  Cary A Moody,et al.  Human papillomavirus oncoproteins: pathways to transformation , 2010, Nature Reviews Cancer.

[15]  E. Boccardo HPV-Mediated Genome Instability: At the Roots of Cervical Carcinogenesis , 2010, Cytogenetic and Genome Research.

[16]  S. Duensing,et al.  Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins , 2009, Environmental and molecular mutagenesis.

[17]  Elizabeth E. Hoskins,et al.  Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin. , 2009, Cancer research.

[18]  F. Radvanyi,et al.  MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors , 2006, Oncogene.

[19]  S. Patil,et al.  Amplification of the chromosome 20q region is associated with expression of HPV-16 E7 in human airway and anogenital epithelial cells. , 2005, Virology.

[20]  Ruud H. Brakenhoff,et al.  CGHMultiArray: exact P-values for multi-array comparative genomic hybridization data , 2005, Bioinform..

[21]  V. Kalscheuer,et al.  A region on human chromosome 4 (q35.1→qter) induces senescence in cell hybrids and is involved in cervical carcinogenesis , 2005, Genes, chromosomes & cancer.

[22]  C. Meijer,et al.  HPV-mediated transformation of the anogenital tract. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[23]  C. R. Leemans,et al.  Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients. , 2005, Cancer research.

[24]  C. Meijer,et al.  Telomerase activity in high‐grade cervical lesions is associated with allelic imbalance at 6Q14–22 , 2003, International journal of cancer.

[25]  K. Münger,et al.  The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. , 2002, Cancer research.

[26]  S. Månér,et al.  Genetic alterations in cervical carcinomas: Frequent low‐level amplifications of oncogenes are associated with human papillomavirus infection , 2002, International journal of cancer.

[27]  A. Zetterberg,et al.  Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas , 2002, Genes, chromosomes & cancer.

[28]  J. Hackett,et al.  Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis , 2002, Oncogene.

[29]  M. Stanley,et al.  Early genetic events in HPV immortalised keratinocytes , 2001, Genes, chromosomes & cancer.

[30]  A. Zetterberg,et al.  Frequent amplification of the telomerase reverse transcriptase gene in human tumors. , 2000, Cancer research.

[31]  C. Reznikoff,et al.  Dominant genetic alterations in immortalization: Role for 20q gain , 1999, Genes, chromosomes & cancer.

[32]  C. Meijer,et al.  Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. , 1998, Cancer research.

[33]  C. Meijer,et al.  Non‐random allelic losses at 3p, 11p and 13q during HPV‐mediated immortalization and concomitant loss of terminal differentiation of human keratinocytes , 1998, International journal of cancer.

[34]  P. Lichter,et al.  Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Elena Savelieva,et al.  20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells , 1997, Oncogene.

[36]  C. Meijer,et al.  Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. , 1996, Oncogene.

[37]  H. zur Hausen,et al.  Malignant progression of an HPV16-immortalized human keratinocyte cell line (HPKIA) in vitro. , 1995, Cancer genetics and cytogenetics.

[38]  S. Barber,et al.  Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells , 1994, Molecular and cellular biology.

[39]  J. Abastado,et al.  HPV 16E 2 induces prophase arrest and activates the cellular DNA damage response in vitro and in precursor lesions of cervical carcinoma , 2015 .

[40]  M. von Knebel Doeberitz,et al.  Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract - a systematic review and meta-analysis. , 2014, European journal of cancer.

[41]  Franck Picard,et al.  Preprocessing and downstream analysis of microarray DNA copy number profiles , 2011, Briefings Bioinform..

[42]  E. Schröck,et al.  Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. , 1999, Cancer research.